Cargando…

Alkyne as a Latent Warhead to Covalently Target SARS-CoV-2 Main Protease

[Image: see text] There is an urgent need for improved therapy to better control the ongoing COVID-19 pandemic. The main protease M(pro) plays a pivotal role in SARS-CoV-2 replications, thereby representing an attractive target for antiviral development. We seek to identify novel electrophilic warhe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ngo, Chau, Fried, William, Aliyari, Saba, Feng, Joshua, Qin, Chao, Zhang, Shilei, Yang, Hanjing, Shanaa, Jean, Feng, Pinghui, Cheng, Genhong, Chen, Xiaojiang S., Zhang, Chao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Chemical Society 2023
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10510381/ https://www.ncbi.nlm.nih.gov/pubmed/37595260 http://dx.doi.org/10.1021/acs.jmedchem.3c00810

Ejemplares similares

Exploring the Versatility of the Covalent Thiol–Alkyne Reaction with Substituted Propargyl Warheads: A Deciding Role for the Cysteine Protease
por: Mons, Elma, et al.
Publicado: (2021)

Characterising covalent warhead reactivity
por: Martin, James S., et al.
Publicado: (2019)

A Warhead Substitution Study on the Coronavirus Main Protease Inhibitor Nirmatrelvir
por: Vankadara, Subramanyam, et al.
Publicado: (2022)

Identification of pyrogallol as a warhead in design of covalent inhibitors for the SARS-CoV-2 3CL protease
por: Su, Haixia, et al.
Publicado: (2021)

Bicyclobutanes: from curiosities to versatile reagents and covalent warheads
por: Kelly, Christopher B., et al.
Publicado: (2022)

Covalent Reversible Inhibitors of Cysteine Proteases Containing the Nitrile Warhead: Recent Advancement in the Field of Viral and Parasitic Diseases
por: Brogi, Simone, et al.
Publicado: (2022)

Systematic Exploration of Privileged Warheads for Covalent Kinase Drug Discovery
por: Zhao, Zheng, et al.
Publicado: (2022)

Rhenium(V) Complexes as Cysteine-Targeting Coordinate Covalent Warheads
por: Karges, Johannes, et al.
Publicado: (2023)

Covalent Warheads Targeting Cysteine Residue: The Promising Approach in Drug Development
por: Huang, Fangjiao, et al.
Publicado: (2022)

Alkyne Derivatives of SARS-CoV-2 Main Protease Inhibitors Including Nirmatrelvir Inhibit by Reacting Covalently with the Nucleophilic Cysteine
por: Brewitz, Lennart, et al.
Publicado: (2023)

Structure-based design of a dual-warhead covalent inhibitor of FGFR4
por: Chen, Xiaojuan, et al.
Publicado: (2022)

Development of a covalent cereblon-based PROTAC employing a fluorosulfate warhead
por: Nowak, Radosław P., et al.
Publicado: (2023)

SARS-CoV-2 virus NSP14 Impairs NRF2/HMOX1 activation by targeting Sirtuin 1
por: Zhang, Shilei, et al.
Publicado: (2022)

The Alkyne Moiety as a Latent Electrophile in Irreversible Covalent Small Molecule Inhibitors of Cathepsin K
por: Mons, Elma, et al.
Publicado: (2019)

Author Correction: Structure-based design of a dual-warhead covalent inhibitor of FGFR4
por: Chen, Xiaojuan, et al.
Publicado: (2022)

Assessment of Covalently Binding Warhead Compounds in the Validation of the Cytomegalovirus Nuclear Egress Complex as an Antiviral Target
por: Tillmanns, Julia, et al.
Publicado: (2023)

Phosphinate esters as novel warheads for activity-based probes targeting serine proteases
por: Kahler, Jan Pascal, et al.
Publicado: (2021)

The Evolutionary Dance between Innate Host Antiviral Pathways and SARS-CoV-2
por: Aliyari, Saba R., et al.
Publicado: (2022)

Species-specific lipophilicities of fluorinated diketones in complex equilibria systems and their potential as multifaceted reversible covalent warheads
por: Columbus, Ishay, et al.
Publicado: (2023)

The colibactin warhead crosslinks DNA
por: Vizcaino, Maria I., et al.
Publicado: (2015)

Impact of the Warhead of Dipeptidyl Keto Michael Acceptors on the Inhibition Mechanism of Cysteine Protease Cathepsin L
por: Fernández-de-la-Pradilla, Adrián, et al.
Publicado: (2023)

Investigation of the Compatibility between Warheads and Peptidomimetic Sequences of Protease Inhibitors—A Comprehensive Reactivity and Selectivity Study
por: Müller, Patrick, et al.
Publicado: (2023)

Supercomputer simulation of the covalent inhibition of the main protease of SARS-CoV-2
por: Nemukhin, A. V., et al.
Publicado: (2022)

Protease cleavage of RNF20 facilitates coronavirus replication via stabilization of SREBP1
por: Zhang, Shilei, et al.
Publicado: (2021)

Dynamic covalent synthesis of aryleneethynylene cages through alkyne metathesis: dimer, tetramer, or interlocked complex?
por: Wang, Qi, et al.
Publicado: (2016)

Selective covalent targeting of SARS-CoV-2 main protease by enantiopure chlorofluoroacetamide
por: Yamane, Daiki, et al.
Publicado: (2022)

Sulfonyl fluorides as privileged warheads in chemical biology
por: Narayanan, Arjun, et al.
Publicado: (2015)

Bortezomib Warhead-Switch Confers Dual Activity against Mycobacterial Caseinolytic Protease and Proteasome and Selectivity against Human Proteasome
por: Moreira, Wilfried, et al.
Publicado: (2017)

Covalent narlaprevir- and boceprevir-derived hybrid inhibitors of SARS-CoV-2 main protease
por: Kneller, Daniel W., et al.
Publicado: (2022)

Repurposing Halicin as a potent covalent inhibitor for the SARS-CoV-2 main protease
por: Yang, Kai S., et al.
Publicado: (2022)

Mechanistic investigation of SARS-CoV-2 main protease to accelerate design of covalent inhibitors
por: Kim, Hoshin, et al.
Publicado: (2022)

Aryl transition metal chemical warheads for protein bioconjugation
por: Bisseret, Philippe, et al.
Publicado: (2018)

Study on Penetration Performance of Rear Shaped Charge Warhead
por: Du, Yanan, et al.
Publicado: (2021)

Andrographolide and its fluorescent derivative inhibit the main proteases of 2019-nCoV and SARS-CoV through covalent linkage
por: Shi, Tzu-Hau, et al.
Publicado: (2020)

Food phytochemicals, epigallocatechin gallate and myricetin, covalently bind to the active site of the coronavirus main protease in vitro
por: Kato, Yoji, et al.
Publicado: (2021)

Virtual screening for small molecular non-covalent binders of the SARS-CoV-2 main protease
por: Lipiński, Piotr F.J., et al.
Publicado: (2021)

Contribution of the catalytic dyad of SARS-CoV-2 main protease to binding covalent and noncovalent inhibitors
por: Kovalevsky, Andrey, et al.
Publicado: (2023)

Photoactivatable metabolic warheads enable precise and safe ablation of target cells in vivo
por: Benson, Sam, et al.
Publicado: (2021)

Evaluation of a non-prime site substituent and warheads combined with a decahydroisoquinolin scaffold as a SARS 3CL protease inhibitor
por: Ohnishi, Kouji, et al.
Publicado: (2019)

Warhead biosynthesis and the origin of structural diversity in hydroxamate metalloproteinase inhibitors
por: Leipoldt, Franziska, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_tgt8jc7cfff71qaole9ljqlq5i